These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10861420)

  • 1. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.
    Goldberg SN; Gazelle GS; Compton CC; Mueller PR; Tanabe KK
    Cancer; 2000 Jun; 88(11):2452-63. PubMed ID: 10861420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.
    Morimoto M; Sugimori K; Shirato K; Kokawa A; Tomita N; Saito T; Tanaka N; Nozawa A; Hara M; Sekihara H; Shimada H; Imada T; Tanaka K
    Hepatology; 2002 Jun; 35(6):1467-75. PubMed ID: 12029632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode.
    Rossi S; Buscarini E; Garbagnati F; Di Stasi M; Quaretti P; Rago M; Zangrandi A; Andreola S; Silverman D; Buscarini L
    AJR Am J Roentgenol; 1998 Apr; 170(4):1015-22. PubMed ID: 9530052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
    Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
    Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma.
    Buscarini L; Buscarini E; Di Stasi M; Quaretti P; Zangrandi A
    Ultraschall Med; 1999 Apr; 20(2):47-53. PubMed ID: 10407974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New applications of ultrasonography: interventional ultrasound.
    Solbiati L
    Eur J Radiol; 1998 May; 27 Suppl 2():S200-6. PubMed ID: 9652523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
    Jung EM; Clevert DA; Rupp N
    Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation for treatment of hepatocellular carcinoma with cirrhosis.
    Lo HW; Tsai YJ; Chen PH; Chen HY; Ker CG; Juan CC
    Hepatogastroenterology; 2003; 50(51):645-50. PubMed ID: 12828052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic assessment of radiofrequency ablation of pulmonary metastases.
    Jaskolka JD; Kachura JR; Hwang DM; Tsao MS; Waddell TK; Asch MR; Darling GE; Johnston MR
    J Vasc Interv Radiol; 2010 Nov; 21(11):1689-96. PubMed ID: 20884239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrasonically controlled percutaneous high frequency thermotherapy of liver tumors with perfused needle electrodes].
    Holtkamp W; Müller W
    Z Gastroenterol; 2000 Mar; 38(3):221-7. PubMed ID: 10768244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy.
    Goldberg SN; Kamel IR; Kruskal JB; Reynolds K; Monsky WL; Stuart KE; Ahmed M; Raptopoulos V
    AJR Am J Roentgenol; 2002 Jul; 179(1):93-101. PubMed ID: 12076912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiofrequency ablation: basic principles, techniques and challenges].
    Pereira PL; Trübenbach J; Schmidt D
    Rofo; 2003 Jan; 175(1):20-7. PubMed ID: 12525976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases.
    Goldberg SN; Solbiati L; Hahn PF; Cosman E; Conrad JE; Fogle R; Gazelle GS
    Radiology; 1998 Nov; 209(2):371-9. PubMed ID: 9807561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy.
    Tanis E; Spliethoff JW; Evers DJ; Langhout GC; Snaebjornsson P; Prevoo W; Hendriks BH; Ruers TJ
    Eur J Surg Oncol; 2016 Feb; 42(2):251-9. PubMed ID: 26746090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.
    Gillams AR; Lees WR
    J Vasc Interv Radiol; 2008 May; 19(5):712-7. PubMed ID: 18440460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteria.
    Seror O; N'Kontchou G; Van Nhieu JT; Rabahi Y; Nahon P; Laurent A; Trinchet JC; Cherqui D; Vicaut E; Beaugrand M; Sellier N
    J Vasc Interv Radiol; 2014 Apr; 25(4):599-607. PubMed ID: 24529547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.